Zhang, Zheng
Article History
Received: 31 May 2026
Accepted: 26 June 2026
First Online: 5 August 2026
Declarations
Ethics approval and consent to participate: This study was approved by the Research Ethics Committee of China Pharmaceutical University (Reference Number: CPU-IRB-2024–0537). All participants provided written informed consent prior to enrollment. The study was conducted in accordance with the Declaration of Helsinki and relevant national regulations.
Consent for publication: All authors have reviewed the manuscript and consent to its publication. No identifiable information regarding participants has been included.
Competing interests: The authors declare no competing interests.